XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Statements of Operations (unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Product revenue $ 32,049 $ 40,096 $ 102,381 $ 129,810
Cost of product revenue 38,462 61,935 158,113 210,429
Product gross profit (loss) (6,413) (21,839) (55,732) (80,619)
Collaborations revenue 17,451 6,374 59,838
Operating expenses:        
Selling, general and administrative 1,529,670 2,129,474 5,090,018 4,636,586
Research and development 1,225,351 901,134 3,491,193 2,916,721
Total operating expenses 2,755,021 3,030,608 8,581,211 7,553,307
Loss from operations (2,761,434) (3,034,996) (8,630,569) (7,574,088)
Interest expense (3,053)
Net valuation change of instruments measured at fair value 1,974
Other income 1,707 83,387 5,300 270,162
Loss before income taxes (2,759,727) (2,951,609) (8,625,269) (7,305,005)
Provision for income taxes
Net loss $ (2,759,727) $ (2,951,609) $ (8,625,269) $ (7,305,005)
Net loss per share:        
Basic and diluted (in Dollars per share) $ (0.17) $ (0.25) $ (0.54) $ (0.71)
Number of shares used in per share calculations:        
Basic and diluted (in Shares) 16,193,442 11,959,101 15,927,734 10,269,216